 |
 |
|
|
RESÚMENES JUNIO 2006 |
Psychotic Disorders & Antipsychotics
(Haga un click en la información del journal
para acceder al resúmen)
Reasons for cannabis use in
psychosis
David
Schofield, Chris Tennant, Louise Nash, Louisa Degenhardt,
Alison Cornish, Coletta Hobbs, Gail Brennan
Australian and New Zealand Journal of Psychiatry. Volume 40 Page 570 - June 2006
Smoking and schizophrenia:
is symptom profile related to smoking and which antipsychotic medication is of
benefit in reducing cigarette use?
Mark
Barnes, Bruce R. Lawford, Simon C. Burton, Karen R. Heslop, Ernest P. Noble, Karrin Hausdorf, Ross McD. Young
Australian
and New Zealand Journal of Psychiatry. Volume 40 Page 575 - June 2006
Seasonality effects on schizophrenic births
in multiplex families in a tropical island
Jose R. Carrión-Baralt,
Christopher J. Smith, Enrique Rossy-Fullana, Roberto
Lewis-Fernández, Kenneth L. Davis and Jeremy M.
Silverman
Psychiatry Research. Volume 142, Issue 1, 30 May 2006, Pages 93-97
NICE guidance in schizophrenia: how generalisable are drug trials?
Tom Burns
Psychiatric Bulletin (2006) 30: 210-212
Brain volume in
first-episode schizophrenia. Systematic review and meta-analysis of magnetic resonance
imaging studies
R. GRANT STEEN, COURTNEY
The British Journal of Psychiatry (2006) 188: 510-518
Self-reported
psychotic symptoms in the general population. Results from the longitudinal study of
the British National Psychiatric Morbidity Survey
NICOLA J. WILES,
The British Journal of Psychiatry (2006) 188: 519-526
Impact of psychological trauma on the
development of psychotic symptoms: relationship with psychosis proneness
JANNEKE
The British Journal of Psychiatry (2006) 188: 527-533
Effectiveness and tolerability of schizophrenia
treatment in Central and
Tamás Treuer,
Martin Anders, Istvan Bitter, Gheorghe Dobre, Jan Pecenak, Yulia Dyachkova, Gavan Harrison,
John O'Mahoney
International Journal of Psychiatry in Clinical
Practice. Volume 10, Number 2 /
June 2006: 78 - 90
Effect of hormone replacement therapy on cognitive
function in women with chronic schizophrenia
Young-Hoon Ko, Sook-Haeng
Joe, Woong Cho, Jeong-Hyun
Park, Jung-Jae Lee, In-Kwa Jung, Leen
Kim, Seung-Hyun Kim
International Journal of Psychiatry in Clinical
Practice. Volume 10, Number 2 /
June 2006: 97 - 104
Minimising the
risk of diabetes in patients with schizophrenia and bipolar disorder
Pierre Chue and Raphael Cheung
International Journal of Psychiatry in Clinical
Practice. Volume 10, Number 2 /
June 2006: 105 - 116
Clinical experience with atypical antipsychotics in an acute inpatient unit: focus on quetiapine
Nicholas
A. Keks, Michael Tonso,
Kelly Tabone, Mary McHugh, Rajan
Thomas, Phil Tune, Mat Gelman
International Journal of Psychiatry in Clinical
Practice. Volume 10, Number 2 /
June 2006: 138 - 141
Atypical
Antipsychotic Agents in the Treatment of Violent Patients With
Schizophrenia and Schizoaffective Disorder
Arch Gen
Psychiatry. 2006;63:622-629
Proof-of-Concept
Trial of an alpha-7 Nicotinic Agonist in Schizophrenia
Ann Olincy, Josette G. Harris, Lynn
L. Johnson, Vicki Pender, Susan Kongs, Diana Allensworth, Jamey Ellis, Gary O. Zerbe,
Sherry Leonard, Karen E. Stevens, James O. Stevens, Laura Martin, Lawrence E.
Adler, Ferenc Soti, William
R. Kem, Robert Freedman
Arch Gen
Psychiatry. 2006;63:630-638
Sex Differences in Outcome and Recovery
for Schizophrenia and Other Psychotic and Nonpsychotic
Disorders
Linda S. Grossman, Martin Harrow, Cherise
Rosen, and Robert Faull
Psychiatr
Serv 57:844-850, June 2006
Diabetes mellitus and antipsychotic treatment
in the
Christopher
Carlson, Kenneth Hornbuckle, Frank DeLisle, Ludmila Kryzhanovskaya, Alan Breier and Patrizia Cavazzoni
European Neuropsychopharmacology. Volume 16, Issue 5, July 2006, Pages 366-375
New-onset type-2 diabetes associated
with atypical antipsychotic medications
Michael
T. Lambert, Laurel A. Copeland, Nancy Sampson and Sonia A. Duffy
Does antipsychotic
withdrawal provoke psychosis? Review of the literature on rapid onset psychosis
(supersensitivity psychosis) and withdrawal-related
relapse
J.
Moncrieff
Acta Psychiatrica
Scandinavica.
Volume
114 Page 3 - July 2006
Health resource utilization
associated with switching to risperidone long-acting
injection
C.
L. Young, D. M. Taylor
Acta Psychiatrica
Scandinavica.
Volume
114 Page 14 - July 2006
Serum concentrations of risperidone
and 9-OH risperidone following intramuscular
injection of long-acting risperidone compared with
oral risperidone medication
R. Nesvåg,
M. Hendset, H. Refsum, L. Tanum
Acta Psychiatrica Scandinavica. Volume 114 Page 21 -
July 2006
Differences in resting energy expenditure and body
composition between patients with schizophrenia and healthy controls
B. M. Nilsson, A. H. Forslund, R. M. Olsson, L. Hambraeus,
F.-A. Wiesel
Acta Psychiatrica Scandinavica. Volume 114 Page 27 -
July 2006
The incidence and prevalence of schizophrenia
varies with latitude
S.
Acta Psychiatrica Scandinavica. Volume 114 Page 36 -
July 2006
Prevalence of Toxoplasma infection in
first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative
schizophrenia
H.-L. Wang, G.-H. Wang, Q.-Y. Li, C. Shu, M.-S. Jiang, Y. Guo
Acta Psychiatrica Scandinavica. Volume 114 Page 40 -
July 2006
Height, weight and body mass index in early
adulthood and risk of schizophrenia
H. J. Sørensen, E. L. Mortensen, J. M. Reinisch,
S. A. Mednick
Acta Psychiatrica Scandinavica. Volume 114 Page 49 -
July 2006
Effects of typical and atypical antipsychotics on glucose–insulin homeostasis and lipid
metabolism in first-episode schizophrenia
Ren-Rong Wu, Jing-Ping Zhao,
Zhe-Ning Liu, Jin-Guo Zhai, Xiao-Feng Guo, Wen-Bing Guo and Jing-Song Tang
Psychopharmacology
2006; Volume 186, Number 4: 572 - 578
Low-Dose
Mirtazapine: A New Option in the Treatment of
Antipsychotic-Induced Akathisia. A Randomized,
Double-Blind, Placebo- and Propranolol-Controlled
Trial
Michael Poyurovsky, Artashes Pashinian, Ronit Weizman, Camil Fuchs and Abraham Weizman
Biological Psychiatry. Volume 59, Issue 11, 1 June 2006, Pages 1071-1077
A Single-blind, Randomized Comparison of Olanzapine at a Starting Dose of 5 mg Versus
20 mg in Acute Schizophrenia
Mauri, Massimo Carlo; Colasanti, Alessandro; Rossattini, Matteo;
Moliterno, Donatella; Baldi, Marialuisa L.; Papa, Pietro
Clinical
Neuropharmacology. 29(3):126-131, May/June 2006
Substance Abuse and the Management of Medication Nonadherence in Schizophrenia
Wilk,
Joshua; Marcus, Steven C.; West, Joyce; Countis,
Lisa; Hall, Rebecca; Regier, Darrel A.; Olfson, Mark
Journal of Nervous & Mental
Disease. 194(6):454-457, June 2006
Quetiapine versus olanzapine
for the treatment of negative symptoms in patients with schizophrenia
Pinkhas Sirota,
Irit Pannet, Ady Koren, Eleonora
Tchernichovsky
Human
Psychopharmacology: Clinical and Experimental. Volume 21,
Issue 4 , Pages 227 - 234
Comparison
between risperidone, olanzapine,
and clozapine in the management of chronic
schizophrenia: a naturalistic prospective 12-week observational study
Rael D. Strous,
Marina Kupchik, Suzana Roitman, Sima Schwartz, Noach Gonen, Roberto Mester, Abraham Weizman, Baruch Spivak
Human
Psychopharmacology: Clinical and Experimental. Volume 21,
Issue 4, Pages 235 - 243
Insulin Resistance and Adiponectin
Levels in Drug-Free Patients With Schizophrenia: A
Preliminary Report
Can J Psychiatry 2006;51:382–386
Haloperidol Dose When Used as Active
Comparator in Randomized Controlled Trials With
Atypical Antipsychotics in Schizophrenia: Comparison
With Officially Recommended Doses
Gerard
W. K. Hugenholtz, Eibert R.
Heerdink, Joost J. Stolker, Welmoed E. E. Meijer,
Antoine C. G. Egberts, and Willem A. Nolen
J Clin Psychiatry 2006;67:897-903
Predicting 5-Year Outcome in First-Episode
Psychosis: Construction of a Prognostic Rating Scale
J Clin Psychiatry 2006;67:916-924
Cognition, schizophrenia and the effect of antipsychotics
E. Stip
L’Encephale. Vol 32 - N° 3 - Juin 2006:341
- 50
Clinical and socio-demographic profile of
patients with schizophrenia according to the antipsychotic treatment prescribed
I. Lamarque, L. Auffray, M. Villamaux, J.-C. Demant,
C. Launay, F. Petitjean, F. Salomé
L’Encephale. Vol 32 - N° 3 - Juin 2006:369 - 76
Side
Effects of Atypical Antipsychotics: Extrapyramidal Symptoms and the Metabolic Syndrome
Arshia A. Shirzadi
and S. Nassir Ghaemi
Harvard Review of
Psychiatry.
Volume 14, Number 3 / May-June 2006: 152
- 164
Levomepromazine versus chlorpromazine in treatment-resistant
schizophrenia: a double-blind randomized trial
Samarthji Lal,
Joseph X. Thavundayil, N.P. Vasavan
Nair, Lawrence Annable, Ng M.K. Ng Ying Kin, Antoine
Gabriel, George Schwartz
J Psychiatry
Neurosci 2006;31(4):271-9
Prevalence of the
diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over
the course of the illness: a cross-sectional study
Marc De Hert, Ruud van Winkel, Dominique Van Eyck, Linda Hanssens,
Martien Wampers, Andre Scheen and Jozef Peuskens
Clinical
Practice and Epidemiology in Mental Health 2006, 2:14;
27 June 2006